German Health Minister Jens Spahn entered the EU on Tuesday calling for export restrictions on coronavirus vaccines in the midst of frustration with the delay in carrying out the AstraZeneca pharmaceutical community to Member States.
Spahn said he supported “vaccines leaving the EU needing a license, so that we at least know what is being produced, what is leaving Europe, and whether there is a fair distribution if it is leaving Europe.”
Due to the complexities of the manufacturing process, delays were understandable, he told the ZDF broadcaster, but they must’ reasonably and equally affect everybody.’
Last Friday, British-Swedish company AstraZeneca said it would not meet its contractual delivery commitments to the European Union because of unexplained “reduced yields” in its European supply chain.
Europe’s regulator EMA has not yet approved AstraZeneca’s vaccine for general use in the bloc.
But the EMA is poised to add AstraZeneca’s to the list of approved vaccines by the end of this week, on the understanding that it would be already on hand and available for immediate rollout.